| Active, not recruiting | 2 | 669 | Canada | mRNA-1273 SARS-CoV-2 vaccine, COVID-19 Vaccine Moderna, Spikevax, BNT162b2, Pfizer-BioNTech COVID-19 Vaccine, Comirnaty, ChAdOx1-S [recombinant], Astra Zeneca COVID-19 Vaccine, COVISHIELD AstraZeneca COVID-19 Vaccine, Vaxzevria, 0, 28 day schedule, 0, 112 day schedule, Covifenz, Medicago COVID-19 vaccine | Canadian Immunization Research Network, Canadian Center for Vaccinology, BC Children's Hospital Research Institute, Children's Hospital Research Institute of Manitoba, CHU de Quebec-Universite Laval, Ottawa Hospital Research Institute, Ontario Agency for Health Protection and Promotion, University of Toronto, Massachusetts General Hospital, Interior Health, McGill University Health Centre/Research Institute of the McGill University Health Centre | COVID-19 | 11/24 | 02/25 | | |
NCT04184336: Enhanced Population-based Core Surveillance of Meningococcal Invasive Infections at Participating Centers Across Canada |
|
|
| Recruiting | N/A | 400 | Canada | surveillance | Canadian Paediatric Society, Pfizer, GlaxoSmithKline | Invasive Meningococcal Disease | 12/22 | 12/22 | | |